Skip to main content

Table 2 Details and schedule of the MindPD trial assessment procedure

From: Distant delivery of a mindfulness-based intervention for people with Parkinson’s disease: the study protocol of a randomised pilot trial

Assessments administered

Screening (week 0)

Baseline (week 1)

Mid-intervention (week 4)

Post-intervention (week 8)

3-month follow-up (week 20)

Main details sheet

X

    

Telephone Interview for Cognitive Status Instrument modified version (TICS-M)

X

    

Demographics sheet

 

X

   

Primary outcome measure:

 Hospital Anxiety and Depression Scale (HADS)

 

X

X

X

X

Secondary outcome measures:

 Parkinson’s Disease Activities of Daily Living Scale (PADLS)

 

X

X

X

X

 Brief Pain Inventory (BPI)

 

X

X

X

X

 Fatigue Severity Scale (FSS)

 

X

X

X

X

 Insomnia Severity Index (ISI)

 

X

X

X

X

Process variables:

 Self-Compassion Scale (SCS)

 

X

X

X

X

 Philadelphia Mindfulness Scale (PHLMS)

 

X

X

X

X

 Experiences Questionnaire (EQ)

 

X

X

X

X

 Acceptance Action Questionnaire (AAQ-II)

 

X

X

X

X

 Intolerance of Uncertainty Scale (IUS-12)

 

X

X

X

X

Health economics variables:

 Subjective Well-Being questionnaire (SWB)

 

X

 

X

X

 EuroQoL and visual analog scale (EQ-5D-3L and VAS)

 

X

 

X

X

 ICEpop CAPability Measure for Adults (ICECAP-A)

 

X

 

X

X

 Adult Social Care Outcomes Toolkit (ASCOT)

 

X

 

X

X

 Home practice

   

X

X